Blog · manufacturing insights
LL-37 Manufacturer Buyer Guide (B2B)
· Peptisova
LL-37 is offered here as a research / industrial catalog peptide API—not as a clinic-dispense product and not as a consumer protocol kit. This buyer guide is for lab and industrial procurement teams qualifying manufacturing supply with documents, method clarity, and reorder discipline.
Commercial SKU: LL-37 5 mg. Hubs: Research procurement, Research APIs. Companion spoke article: Lab procurement documentation checklist.
Who typically buys LL-37 B2B
| Buyer | Intent | What they should lock early |
|---|---|---|
| Lab / industrial R&D procurement | Fixed-spec catalog API + lot COAs | Purity target, HPLC/MS requirements, format |
| Program buyers needing repeats | Reorder lot continuity | Spec version + batch tracker |
| Occasional OEM/industrial packs | Packaging scope only when real | Artwork/release pack vs chemistry-only PO |
We decline consumer dosing calculators and clinic-dispense merchandising (Compliance).
Catalog fact table (confirm soft bands with sales)
| Spec | Catalog framing |
|---|---|
| Compound | LL-37 (research / industrial catalog API) |
| Strength | 5 mg lyophilized vial |
| Purity (typical) | HPLC on lot COA (soft band — confirm with sales / lot file) |
| Format | Lyophilized vial (Track A); custom/bulk via RFQ |
| MOQ (typical) | Track A catalog MOQ on PDP badge (soft band) |
| Commerce | Track A MOQ checkout; custom / bulk / OEM via RFQ |
| Docs | Lot COA (HPLC; MS where specified); packing list; vault sample UX |
| Framing | RUO / industrial — not clinic retail |
These rows mirror storefront PDP enrichment. They are not clinical protocols and not dosing guidance.
Buyer decision framework
- Catalog vs custom — is the fixed LL-37 5 mg SKU enough, or do you need sequence/mods (Custom peptide synthesis)?
- Analytical bar — HPLC only, or MS confirmation required by your internal method (Quality)?
- Format — vial economics vs powder API (vials vs powder)?
- Documentation depth — single COA vs fuller packet (COA vs full QA packet)?
- Language discipline — can every stakeholder keep RUO / industrial framing (Compliance)?
Lab buyers who skip step 5 often inherit RFQ threads contaminated with clinic-dispense language that procurement then has to unwind.
Documentation pack
- Lot-linked COA (COA Vault; What a COA proves).
- HPLC / MS expectations per your spec (Quality; HPLC/MS checklist; read a chromatogram).
- Batch retention across reorders (batch numbers).
- Destination docs listed on RFQ when required (Quote Cart; RFQ fields).
- Building-block context if your lab also buys Fmoc starters for in-house work (Fmoc starter pack).
QC questions for lab procurement
- Will each new production lot include its own COA PDF—not a recycled sample?
- Which methods appear on the COA, and can we request MS when our SOP requires it?
- Who investigates out-of-spec results, and how quickly can QA speak to them?
- How are lot IDs presented for receipt reconciliation against packing lists?
- Confirm RUO / industrial framing only—no reconstitution calculator merchandising.
Ownership diligence: verify hub · manufacturer vs reseller · Fact Sheet.
Catalog MOQ vs custom / OEM / bulk
| Path | When | Entry |
|---|---|---|
| Track A catalog | Fixed-spec LL-37 is enough | LL-37 5 mg · MOQ scale |
| Custom sequence/mods | Outside catalog | Custom peptide synthesis |
| Bulk powder | Volume beyond vial economics | Bulk peptide API |
| OEM/industrial packs | Packaging scope is truly required | OEM private label |
Branded kits are uncommon for this line but possible when your program needs them. Most lab buyers stay on chemistry + documents.
Research-procurement framing
Keep internal and external language in RUO / industrial context:
| Do | Do not |
|---|---|
| Ask for methods and lot IDs | Ask for patient dosing protocols |
| File COAs for QA | Treat COA as clinical efficacy proof |
| Compare manufacturers on ownership | Shop Melanotan/performance mall keywords |
| Separate catalog APIs from free-sequence custom work | Assume every SKU is custom by default |
Supplier scorecard: Alternatives checklist. Scenario hub: Research procurement. Cert hygiene: GMP-ready language.
Related research catalog neighbors
Procurement teams often qualify LL-37 next to other fixed research APIs. Keep navigation on hubs and PDPs—not dosing blogs:
- Research APIs category
- Examples on catalog: Argipressin acetate, Gonadorelin acetate, Somatostatin-14, Thymosin alpha-1
- Custom track: Custom peptide synthesis
Procurement workflow sketch (first 30 days)
A practical lab/industrial sequence for LL-37:
- Confirm RUO / industrial framing with legal/compliance stakeholders so the RFQ never asks for dosing content (Compliance).
- Decide catalog vs custom; if catalog, open LL-37 5 mg and note MOQ badge soft bands.
- Pull a sample COA from the COA Vault to train receiving on document shape.
- Place Track A PO or send a complete RFQ via Quote Cart with HPLC/MS and destination docs listed.
- On receipt, match lot IDs across COA, packing list, and labels; archive in your batch tracker (batch numbers).
- Only then schedule the next reorder—against the same approved spec unless you intentionally open a new qualification.
Teams that invert this order (reorder first, documentation later) create silent drift that only shows up when an audit or customer QA asks for the ship-lot file.
What this page is NOT
This guide is not:
- Clinic-dispense or patient-protocol merchandising
- A reconstitution or dosing calculator
- Consumer wellness or performance-stack marketing
- Melanotan adjacency
- A claim that a COA proves clinical efficacy
Boundaries: Compliance · Fact Sheet.
RFQ stub (lab / industrial)
> LL-37 RFQ: SKU ll-37-5mg (or custom sequence/mods); quantity ___; format [vial/powder]; purity target ___; HPLC [yes]; MS [required/not]; destination docs ___; prior lot IDs to retain ___; target ship window ___.
Submit via Quote Cart. Catalog MOQ purchases can start on the PDP.
Related reading
- Lab procurement peptide documentation checklist
- HPLC/MS QC checklist
- What a peptide COA proves
- RFQ fields that speed custom quotes
- Product PDP · Quote
Next step
Open LL-37 5 mg, review COA Vault, then MOQ purchase or structured RFQ via Quote Cart.
Peptisova supplies LL-37 for B2B research and industrial contexts only—not consumer or clinic-dispense programs.
FAQ
Is LL-37 sold for clinic dispense here?
No—research/industrial B2B supply. See LL-37 5 mg.
What documents should procurement file?
Lot COAs and specs—start at COA Vault and Quality; fuller packet guidance in COA vs full QA packet.
Can we get a custom quantity or format?
Yes via Quote Cart / Custom peptide synthesis / Bulk peptide API.
How do we verify the manufacturer?
Verify hub.
Do you provide dosing protocols?
No. RUO / industrial supply only (Compliance).
Is every research SKU custom?
No—many fixed catalog APIs on Track A; custom is Track B RFQ.
Next step
Continue on the primary resource for this topic, then use secondary links below for docs and RFQ.